Amphion Innovations plc
Annual General Meeting Results

London and New York, 13 August 2013 – Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces that all resolutions were passed at the Annual General Meeting, which was held on Tuesday 13 August 2013. 


For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Novella Communications
Tim Robertson
+44 (0)7900 927 650

Panmure Gordon Limited
Freddy Crossley / Grishma Patel (Corporate Finance)
Adam Pollock / Victoria Boxall (Corporate Broking)
+44 020 7886 2500

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com

Top